MI tumor Seek Hybrid™, a Novel Combined WES and WTS Molecular Profiling Assay with a Single Extraction and Sequencing Workflow

Join Dr. Matthew Oberley as he presents Caris Life Sciences’ innovative simul-capture approach for combining whole exome and whole transcriptome sequencing into one assay. By simultaneously capturing DNA and RNA, MI Tumor Seek Hybrid™ provides a comprehensive molecular blueprint that saves tissue without compromising results and delivers transformative value across the healthcare ecosystem. Join us to learn about MI tumor Seek Hybrid™ and how it can help guide treatment decisions and improve patient outcomes.